Nomination Summary for Celebrex & Bextra (N20501)
Nomination Date: 10/08/2004
Nominator: Private Individual
Rationale: Vioxx, a popular drug used to treat arthritis, was removed from the market when it was discovered that it increased the risk of heart attack and stroke. Two other COX-2 inhibitors, Celebrex & Bextra, should be studied to determine if they have similar side effects.
NTP Principles: not specified
Status: In Review/Pending